mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.4 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |